Stemmer Imaging AG: Shares To Be Delisted From Trading

Delisting to Take Effect on March 1, 2023

Stemmer Imaging AG, a leading provider of imaging technology solutions, has announced that its shares will be delisted from trading on the Euronext Amsterdam and Frankfurt Stock Exchanges on March 1, 2023.

Background of the Decision

The decision to delist was made after careful consideration by the company's management and board of directors. Stemmer Imaging stated that the delisting is intended to simplify the company's corporate structure and reduce administrative costs, allowing it to focus on its core business operations.

Impact on Shareholders

Stemmer Imaging emphasized that the delisting will not affect the company's ongoing operations or its commitment to its customers and partners. However, shareholders who currently hold Stemmer Imaging shares will no longer be able to trade them on the public markets after the delisting date.

Company's Future Plans

Despite the delisting, Stemmer Imaging remains optimistic about its future prospects. The company intends to continue investing in its technology and expanding its market presence. Stemmer Imaging believes that the delisting will provide it with greater flexibility to pursue growth opportunities and create long-term value for its stakeholders.

Additional Information

For more information regarding the delisting process, shareholders can refer to the company's website or contact Stemmer Imaging directly.

Stemmer Imaging AG is a leading global supplier of imaging technology solutions. The company provides a comprehensive range of products and services, including cameras, lenses, illumination, software, and systems. Stemmer Imaging serves customers in various industries, such as automation, medical, scientific research, and defense.